Healthcare | February 15, 2022
India’s tech-enabled vaccination drive applauded at India-Africa Health Summit
It will open new frontier for south-to-south collaboration and innovation transfer
It will open new frontier for south-to-south collaboration and innovation transfer
Monitoring results demonstrated a good safety profile of the combination. No serious adverse events related to vaccination were registered
Immune responses were about two-to-three-fold higher in adolescents than in adults against all variants studied. Vaccine was well-tolerated with no safety signals identified
_256_384.jpg){kind=logo}
Shilpa Biologicals has tie-ups with Zydus to supply ZyCoV-D vaccine drug substance and Dr Reddy’s to make Sputnik V from its facility in Dharwad
It is being developed by Pune-based Gennova Biopharmaceuticals
Wockhardt has entered into an agreement with Russian Direct Investment Fund and Enso Healthcare to manufacture and supply Sputnik V and Sputnik Light vaccines against Covid-19
Pfizer and Moderna are also working on vaccines that target the Omicron variant
Highest safety and efficacy of Sputnik V confirmed during clinical trials and in real-world use in more than 60 countries around the world
The need is to vaccinate people who have not contracted Covid-19
The vaccine will be priced at Rs. 265 per dose and the applicator being offered at Rs. 93 per dose excluding GST
Subscribe To Our Newsletter & Stay Updated
